Acadia Healthcare (ACHC, Financial) saw a significant drop in its stock price, falling 5.05% to $59.26 per share, with a trading volume of 508,780 shares and a turnover rate of 0.55%, marked by a volatility of 4.80%.
Recent financial reports indicate Acadia Healthcare generated revenues of $796 million, achieving a net profit of $78.48 million and earnings per share of $0.86. The company reported a gross profit of $191 million, with a notably high P/E ratio of -742.81.
Analyst ratings show that 77% of the 13 participating institutions recommend buying ACHC, while 23% suggest holding the stock, with no sell ratings.
In the healthcare facilities sector, the overall decline was 0.31%. Among the related stocks, Modivcare Inc., Thai and Thrive Medical, and Newgenivf Group Limited saw significant gains. Active stocks in the sector include Modivcare Inc., Agilon Health, Inc., and Cross Country Healthcare, Inc., with turnover rates of 5.12%, 2.34%, and 1.37%, respectively. High volatility was observed in The Oncology Institute Inc, Agilon Health, Inc., and Modivcare Inc., with volatilities of 18.88%, 17.03%, and 13.29%, respectively.
Acadia Healthcare Co Inc specializes in the acquisition and development of behavioral healthcare facilities in the US, UK, and Puerto Rico. The company's primary revenue in the US comes from Medicaid and commercial payers, while in the UK, revenues are primarily derived from the National Health Service.
